Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis

BACKGROUND: Despite the prominent position of methotrexate (MTX) in Rheumatoid Arthiris (RA) therapeutics, its real-world effectiveness may be influenced by a relative lack of tolerability or other side effects that physicians may not be aware of but that are bothersome to patients. The aim of this...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Musculoskelet Disord
Asıl Yazarlar: Curtis, J. R., Xie, F., Mackey, D., Gerber, N., Bharat, A., Beukelman, T., Saag, K. G., Chen, L., Nowell, B., Ginsberg, S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5037591/
https://ncbi.nlm.nih.gov/pubmed/27669978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-016-1254-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller